Literature DB >> 16930170

Should criteria for drug dependence differ across drugs?

John R Hughes1.   

Abstract

AIM: To examine the pros and cons of using the same diagnostic criteria for dependence across all drugs versus using dependence criteria specific to the drug of interest.
METHODS: A qualitative review of the similarities and differences in nicotine versus alcohol and opiate dependence is used as an example of the utility of using generic versus drug-specific criteria.
RESULTS: Many scientists implicitly recognize that nicotine dependence is different when they do not include nicotine dependence when studying 'drug dependence'. Nicotine and alcohol/opiate dependence have many similarities (e.g. both can cause withdrawal). Among the several differences, the most important is that nicotine dependence does not cause acute behavioral impairment. Some of the generic dependence criteria do not apply to nicotine dependence (e.g. giving up activities to use the drug) and some well-validated measures of nicotine dependence (e.g. time to first cigarette) are not included in the generic criteria.
CONCLUSIONS: Empirical tests of the relative utility of generic versus drug-specific criteria are needed.

Entities:  

Mesh:

Year:  2006        PMID: 16930170     DOI: 10.1111/j.1360-0443.2006.01588.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  27 in total

1.  Relationship of substance abuse to dependence in the U.S. general population.

Authors:  Tulshi D Saha; Thomas Harford; Risë B Goldstein; Bradley T Kerridge; Deborah Hasin
Journal:  J Stud Alcohol Drugs       Date:  2012-05       Impact factor: 2.582

2.  Euphoriant effects of nicotine in smokers: fact or artifact?

Authors:  Reuven Dar; Rachel Kaplan; Lior Shaham; Hanan Frenk
Journal:  Psychopharmacology (Berl)       Date:  2007-01-19       Impact factor: 4.530

3.  An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study.

Authors:  Li-Tzy Wu; Jeng-Jong Pan; Dan G Blazer; Betty Tai; Maxine L Stitzer; Robert K Brooner; George E Woody; Ashwin A Patkar; Jack D Blaine
Journal:  J Stud Alcohol Drugs       Date:  2009-05       Impact factor: 2.582

4.  Exploring the role of a nicotine quantity-frequency use criterion in the classification of nicotine dependence and the stability of a nicotine dependence continuum over time.

Authors:  Orla McBride; David R Strong; Christopher W Kahler
Journal:  Nicotine Tob Res       Date:  2010-01-15       Impact factor: 4.244

Review 5.  The reinforcement threshold for nicotine as a target for tobacco control.

Authors:  Mehmet Sofuoglu; Mark G LeSage
Journal:  Drug Alcohol Depend       Date:  2012-05-21       Impact factor: 4.492

6.  DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5.

Authors:  Timothy B Baker; Naomi Breslau; Lirio Covey; Saul Shiffman
Journal:  Addiction       Date:  2012-02       Impact factor: 6.526

Review 7.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

8.  Validity of proposed DSM-5 diagnostic criteria for nicotine use disorder: results from 734 Israeli lifetime smokers.

Authors:  D Shmulewitz; M M Wall; E Aharonovich; B Spivak; A Weizman; A Frisch; B F Grant; D Hasin
Journal:  Psychol Med       Date:  2013-01-14       Impact factor: 7.723

Review 9.  Evaluating the Validity of Caffeine Use Disorder.

Authors:  Alan J Budney; Dustin C Lee; Laura M Juliano
Journal:  Curr Psychiatry Rep       Date:  2015-09       Impact factor: 5.285

Review 10.  Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects.

Authors:  Dvora Shmulewitz; Emily R Greene; Deborah Hasin
Journal:  Alcohol Clin Exp Res       Date:  2015-09-01       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.